The Universal Prescription for Parkinson's Disease: Exercise.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert dosing recommendations without systematic review methodology
PubMed 32925109 · doi:10.3233/JPD-202100
What was done
Narrative review synthesizing evidence from animal studies and completed human clinical trials evaluating aerobic exercise, particularly high-intensity aerobic exercise, for structural brain changes and motor symptom management in Parkinson's disease to define specific prescription guidelines.
What was found
The abstract reports no primary statistical outcome values or effect sizes. It outlines a clinical exercise prescription derived from completed trials: 3 sessions per week, 30 to 40 minutes per main exercise set, at 60% to 80% heart rate reserve, 70% to 85% maximum heart rate, or an exertion rating of 14 to 17 on a 20-point scale.
Why it matters
Provides clinicians with concrete aerobic exercise dosing parameters (frequency, duration, and objective intensity thresholds) to replace non-specific physical activity guidance for Parkinson's disease.
Limits
As a narrative review, no systematic search methodology, trial inclusion criteria, or pooled quantitative results are provided in the abstract. Sample sizes and patient characteristics from underlying trials are not reported, and individualized exercise tailoring remains dependent on ongoing trials.
Cited by
- supports Most exercise clinical studies in Parkinson's disease utilize an intervention frequency of approximately three times per week for at least 30 minutes.